Background: Obvious cell kidney cell carcinoma (ccRCC) may be the primary element of kidney cell carcinoma (RCC), and advanced ccRCC frequently signifies an undesirable prognosis. The value of the CCCH-type zinc finger (CTZF) gene in cancer continues to be more and more shown in the past couple of years. Based on studies, targeted radical therapy for cancer treatment can be a revolutionary therapeutic approach. Both lncRNAs and CCCH-type zinc finger genes are crucial in ccRCC. However, the predictive role of lengthy non-coding RNA (lncRNA) connected using the CCCH-type zinc finger gene in ccRCC needs further elucidation. This research aims to calculate patient prognosis and investigate immunological profile of ccRCC patients using CCCH-type zinc finger-connected lncRNAs (CTZFLs). Methods: In the Cancer Genome Atlas database, RNA-seq and corresponding clinical and prognostic data of ccRCC patients were downloaded. Univariate and multivariate Cox regression analyses were conducted to get CTZFLs for constructing conjecture models. The danger model was verified using receiver operating characteristic curve analysis. The Kaplan-Meier method was utilized to evaluate the general survival (OS) of high-risk and occasional-risk groups. Multivariate Cox and stratified analyses were utilised to evaluate the prognostic worth of the predictive feature within the entire cohort and various subgroups. Additionally, the connection between risk scores, immunological status, and treatment response was studied. Results: We built a signature composed of eight CTZFLs (LINC02100, AC002451.1, DBH-AS1, AC105105.3, AL357140.2, LINC00460, DLGAP1-AS2, AL162377.1). The outcomes shown the prognosis of ccRCC patients was individually predicted by CTZFLs signature which the prognosis of high-risk groups was poorer compared to the low group. CTZFLs markers had the greatest diagnostic adequacy when compared with single clinicopathologic factors, as well as their AUC (area underneath the receiver operating characteristic curve) was .806. The general survival of high-risk groups was shorter compared to low-risk groups when patients were split into groups according to several clinicopathologic factors. There have been substantial variations in immunological function, immune cell score, and immune checkpoint expression between high- and occasional-risk groups. Furthermore, Four agents, including ABT737, WIKI4, afuresertib, and GNE 317, were more sensitive within the high-risk group. Conclusion: The Eight-CTZFLs prognostic signature can be a useful prognostic indicator and could assist with medication choice for obvious cell kidney cell carcinoma.GNE-317